Healthcare professionals will accept generic HIV treatments

Generics and Biosimilars Initiative Journal (GaBI Journal). 2017;6(3):148.
DOI: 10.5639/gabij.2017.0603.029

Published in: Volume 6 / Year 2017 / Issue 3
Category: Research News
Page: 148
Author(s):
Visits: 163 total, 1 today

Healthcare professionals working with HIV patients in high-income countries are likely to accept the introduction of generic antiretroviral drugs (ARVs), according to a study carried out by researchers in Ireland [1].

Between the end of August and November 2015, 30 healthcare professionals completed an online survey about the introduction of generic ARVs. Descriptive and univariate analysis revealed information on cohort demographics, knowledge of generic medicine and facilitators of generics substitution.

The sample of healthcare professionals that completed the survey included 22 physicians, four nurse specialists and four pharmacists. 66% of the healthcare professionals had been working in the field of HIV treatment for over five years. They expressed good knowledge of the terms associated with generic medicines and the majority stated that generic medicines contained the same drug as the branded alternative and are as safe and effective.

The healthcare professionals view
The majority of the healthcare professionals that completed the survey expressed concerns about the supply chain of generics. They also noted that the main disadvantages in switching to generic ARVs were related to the loss of fixed-dose combinations of medication, potential negative effects on adherence and the use of older medications. In addition, the majority of healthcare professionals noted that an increase in dosing frequency or pill burden would affect their willingness to prescribe a generic ARV.

Despite concerns, the overall results showed that healthcare professionals would be willing to prescribe generic ARVs if they became available, with 30% stating ‘Yes’, 43% stating ‘Yes, in some cases’, and 27% stating ‘Yes, on a case-by-case basis’. The survey also showed that healthcare professionals have good understanding of the cost of ARVs and generics alternatives, and saw financial advantages in making a switch to generics.

The authors believe that the results show that generics substitution would be acceptable to the majority of healthcare professionals in Ireland. Education programmes targeted at healthcare professionals should be implemented to ease transition and reduce misconceptions about generic ARVs. However, barriers to substitution are likely to be encountered with increased dosing regime or pill burden. The authors also state that the savings made through administration of generic ARVs that can be reinvested into HIV services, will be a powerful motivation for their implementation by healthcare professionals.

References

1. Kieran JA, O’Reilly E, O’Dea S, Bergin C, O’Leary A. Generic substitution of antiretrovirals: patients’ and health care providers’ opinions. Int J STD AIDS. 2017:956462417696215.

Disclosure of Conflict of Interest Statement is available upon request.

Copyright © 2017 Pro Pharma Communications International

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Go Back Print

Leave a Reply